European Commission publishes approval of Octapharma’s human cell line recombinant FVIII (Nuwiq®) across all age groups in haemophilia A

Lachen, Switzerland, August 5th, 2014: The European Commission has published approval of Octapharma’...

Octapharma USA Announces FDA Approval of octagam® 10%, expanding its Immune Globulin Therapy Portfolio

LACHEN, Switzerland, July 17th, 2014: Octapharma USA announce the U.S. Food and Drug Administration ...

Meet us globally

Since its establishment over 30 years ago, Octapharma has grown into a truly global company providing life enhancing therapies to patients in over 100 countries. To find your local Octapharma office, access our global locations map


Octapharma’s success is the result of the combined contribution of all employees, what we call “the human factor”. To embark on a challenging and rewarding career in an innovative biopharmaceutical organization, explore our global opportunities